| Financial Year |
March 31 2023 |
| Monetary Funds |
555,284,119.25 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,004,248.22 |
| Accounts Receivable |
1,082,978,986.34 |
| Advances to Suppliers |
32,803,534.15 |
| Other Receivables |
22,248,251.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
308,433,666.89 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,823,952.26 |
| Total Current Assets |
2,086,325,371.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
74,679,330.59 |
| Under-construction Projects |
8,645,174.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
32,922,839.97 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,949,981.07 |
| Deferred Income Tax Assets |
47,381,600.88 |
| Other Non-Current Assets |
50,378,356.56 |
| Sub-Total of Non-Current Assets |
232,998,938.26 |
| Total Assets |
2,319,324,309.61 |
| Short-Term Loans |
100,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
211,765,641.11 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,416,355.07 |
| Taxes Payable |
17,918,355.18 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,143,212.77 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,450,551.69 |
| Other Current Liabilities |
30,670,785.70 |
| Sub-Total of Current Liabilities |
646,158,181.19 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
6,736,630.49 |
| Deferred Income Tax Liabilities |
1,536,281.11 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
24,227,732.74 |
| Total Liabilities |
670,385,913.93 |
| Paid-In Capital(Or Share Stock) |
105,600,000.00 |
| Capital Surplus |
1,286,148,640.71 |
| Surplus Reserve |
27,758,581.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
229,431,173.97 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,648,938,395.68 |
| Owner's Equity（Stockholder's Equity） |
1,648,938,395.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,319,324,309.61 |
